These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 22653756

  • 1. MAGE-4 gene m-RNA and TGF in blood as potential biochemical markers for HCC in HCV-infected patients.
    Hussein YM, Morad FE, Gameel MA, Emam WA, El Sawy WH, El Tarhouny SA, Bayomy ES, Raafat N.
    Med Oncol; 2012 Dec; 29(5):3055-62. PubMed ID: 22653756
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of circulating Transforming growth factor-beta1, Glypican-3 and Golgi protein-73 mRNAs expression as predictive markers for hepatocellular carcinoma in Egyptian patients.
    Ibrahim GH, Mahmoud MA, Aly NM.
    Mol Biol Rep; 2013 Dec; 40(12):7069-75. PubMed ID: 24186850
    [Abstract] [Full Text] [Related]

  • 3. MAGE-3 and MAGE-4 genes as possible markers for early detection of metastases in hepatitis C virus Egyptian patients complicated by hepatocellular carcinoma.
    Hussein YM, Ghareib AF, Mohamed RH, Radwan MI, Elsawy WH.
    Med Oncol; 2012 Jun; 29(2):994-9. PubMed ID: 21452042
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Detection of alpha-fetoproteins mRNA and melanoma antigen-1 mRNA in peripheral blood of patients with hepatocellular carcinoma and its clinical significance].
    Yang SZ, Dong JH, Zhu J, Li K, Zhang Y.
    Zhonghua Wai Ke Za Zhi; 2004 Sep 07; 42(17):1060-3. PubMed ID: 15498320
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clinical impact of plasma TGF-beta1 and circulating TGF-beta1 mRNA in diagnosis of hepatocellular carcinoma.
    Dong ZZ, Yao DF, Yao M, Qiu LW, Zong L, Wu W, Wu XH, Yao DB, Meng XY.
    Hepatobiliary Pancreat Dis Int; 2008 Jun 07; 7(3):288-95. PubMed ID: 18522884
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Transforming growth factor-β1 gene expression in hepatocellular carcinoma: a preliminary report.
    Farid IM, Hamza IM, El-Abd DM, Mohyi AM, AbdulLatif MM, Aref AT, Hamza DM.
    Arab J Gastroenterol; 2014 Jun 07; 15(3-4):142-7. PubMed ID: 25475758
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A panel of molecular markers in hepatitis C virus-related hepatocellular carcinoma.
    Elgendy SM, Hessien M, Elsherbiny MM, Abd El-Salam IM, El-Attar IA, El-Asser Ael-B.
    J Egypt Natl Canc Inst; 2005 Dec 07; 17(4):270-8. PubMed ID: 17102821
    [Abstract] [Full Text] [Related]

  • 12. Clinical relevance of increased serum preneoplastic antigen in hepatitis C-related hepatocellular carcinoma.
    Yamashita S, Kato A, Akatsuka T, Sawada T, Asai T, Koyama N, Okita K.
    World J Gastroenterol; 2020 Apr 07; 26(13):1463-1473. PubMed ID: 32308347
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of MAGE-1 and MAGE-3 as tumour-specific markers to detect blood dissemination of hepatocellular carcinoma cells.
    Mou DC, Cai SL, Peng JR, Wang Y, Chen HS, Pang XW, Leng XS, Chen WF.
    Br J Cancer; 2002 Jan 07; 86(1):110-6. PubMed ID: 11857021
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Detection of α-fetoprotein and glypican-3 mRNAs in the peripheral blood of hepatocellular carcinoma patients by using multiple FQ-RT-PCR.
    Yan D, He Q, Chen Y, Wang L, Zhang X.
    J Clin Lab Anal; 2011 Jan 07; 25(2):113-7. PubMed ID: 21438004
    [Abstract] [Full Text] [Related]

  • 16. Diagnostic value of cancer-testis antigen mRNA in peripheral blood from hepatocellular carcinoma patients.
    Zhao L, Mou DC, Peng JR, Huang L, Wu ZA, Leng XS.
    World J Gastroenterol; 2010 Aug 28; 16(32):4072-8. PubMed ID: 20731022
    [Abstract] [Full Text] [Related]

  • 17. Influence of transforming growth factor-β1 and tumor necrosis factor-α genes polymorphisms on the development of cirrhosis and hepatocellular carcinoma in chronic hepatitis C patients.
    Radwan MI, Pasha HF, Mohamed RH, Hussien HI, El-Khshab MN.
    Cytokine; 2012 Oct 28; 60(1):271-6. PubMed ID: 22682513
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Influence of hepatitis C virus infection on circulating levels of sICAM-1 and VEGF in patients with hepatitis C and hepatocellular carcinoma (HCC) and their role in enhancing detection of HCC.
    Helaly GF, Abou Shamaa LA.
    Egypt J Immunol; 2006 Oct 28; 13(1):27-38. PubMed ID: 17974148
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.